Plasminogen activator in acute myeloid leukaemic marrows: u-PA in contrast to t-PA in normal marrow

British Journal of Haematology

Volumn 101, Issue 4, 1998, Pages 626-631

  Mcwilliam, Nicola ^a   Robbie, Linda ^a   Booth, Nuala ^a   Bennett, Bruce ^a,b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Acute leukaemia; Haemorrhage; u PA

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW; ENZYME ANALYSIS; ENZYME INHIBITION; FIBRINOLYSIS; HUMAN; HUMAN TISSUE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ACUTE DISEASE; ANTIPLASMIN; BONE MARROW; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LEUKEMIA, MYELOID; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 0031860063     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00762.x     Document Type: Article

References (39)

1. Bauer, K.A. & Rosenberg, R.D. (1984) Thrombin generation in acute promyelocytic leukemia. Blood, 64, 791-796.
2. Bennett, B., Booth, N.A., Croll, A. & Dawson, A.A. (1984) The bleeding disorder in acute promyelocytic leukaemia; fibrinolysis due to u-PA rather than defibrination. British Journal of Haematology, 71, 511-517.
3. Bennett, B., Croll, A.M., Robbie, L.A. & Herriot, R. (1997) Tumour cell u-PA as a cause of fibrinolytic bleeding in metastatic disease. British Journal of Haematology, 99, 570-574.
4. Bennett, B. & Ogston, D. (1996) Fibrinolytic bleeding disorders. Disorders of Hemostasis, 3rd edn (ed. by O. D. Ratnoff and C. D. Forbes), pp. 296-322. Saunders, Philadelphia.
5. Booth, N.A., Anderson, J.A. & Bennett, B. (1985) Platelet release protein which inhibits plasminogen activators. Journal of Clinical Pathology, 37, 772-777.
6. 2-antiplasmin complexes in bleeding disorders characterized by primary or secondary fibrinolysis. British Journal of Haematology, 56, 545-556.
7. Booth, N.A., Walker, K., Maughan, R. & Bennett, B. (1987) Plasminogen activator in normal subjects after exercise and venous occlusion: t-PA circulates as complexes with Cl-inhibitor and PAI-1. Blood, 69, 1600-1604.
8. Boyd, D. & Brittain, M. (1995) Role of the plasminogen activation system in neoplasia. Fibrinolysis in Disease (ed. by P. Glas-Greenwalt), pp. 1-7. CRC Press, Boca Raton.
9. Bradford, M. (1976) A rapid and sensitive method for for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248-254.
10. Camiolo, S., Markus, G., Englender, L., Siuta, M., Hobika, G. & Kohga, S. (1984) Plasminogen activator content and secretion in explants of neoplastic and benign prostate tissues. Cancer Research, 44, 311-318.
11. Dano, K., Andreasen, P.A., Grondahl-Hansen, J., Kristensen, P., Neilsen, L.S. & Skriver, L. (1985) Plasminogen activators, tissue degradation and cancer. Advances in Cancer Research, 44, 139-266.
12. Gralnick, H.R. & Abrell, E. (1973) Studies on the procoagulant and fibrinolytic activity of promyelocytes in acute promyelocytic leukaemia. British Journal of Haematology, 24, 89-99.
13. Granelli-Piperno, A., Vassalli, J.-D. & Reich, E. (1977) Secretion of plasminogen activator by human polymorphonuclear leucocytes. Journal of Experimental Medicine, 146, 1693-1705.
14. Gurewich, V., Pannell, R., Louie, S., Kelley, P., Suddith, R.L. & Greenleee, R. (1984) Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). Journal of Clinical Investigation, 73, 1731-1739.
15. Jackson, M.R., Moore, N.R., Ritchie, H.R. & Booth, N.A. (1996) Enhanced cell-associated u-PA activity of endothelial cells in response to soluble factors released by blood monocytes. Blood Coagulation and Fibrinolysis, 7, 728.
16. Janicke, F., Schmitt, M., Hafter, R., Hollreider, A., Babic, R., Ulm, K., Gossner, W. & Graeff, H. (1990) Urokinase-type plasminogen activator (u-PA) is a predictor of early relapse in breast cancer. Fibrinolysis, 4, 69-78.
17. Jones, P.A. & DeClerk, Y.A. (1982) Extracellular matrix destruction by invasive tumor cells. Cancer Metastasis Review, 1, 289-317.
18. Liotta, L., Goldfarb, R., Bundage, R., Seigel, G., Terranova, V. & Garbisa, S. (1981) Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Research, 41, 4629-4635.
19. Lowry, O.H., Rosebrough, N.J., Farr, A.L. & Randell, R.J. (1951) Protein measurement with the folin phenol reagent. Journal of Biological Chemistry, 193, 265-275.
20. MacGregor, I.R. & Booth, N.A. (1988) An enzyme-linked immunosorbent assay (ELISA) used to study the cellular secretion of endothelial plasminogen activator inhibitor. Thrombosis and Haemostasis, 59, 68-72.
21. MacGregor, I.R., MacDonald, S., Dawes, J., Micklem, L.R. & James, K. (1987) A monoclonal antibody enzyme linked immunosorbent assay (ELISA) directed towards a fibrin binding region of tissue-type plasminogen activator. Fibrinolysis, 1, 247-252.
22. McWilliam, N.A., Robbie, L.A., Barelle, C.J., Adey, G., Prasad, S., Bennett, B. & Booth, N.A. (1996) Evidence for an active fibrinolytic system in normal human bone marrow. British Journal of Haematology, 93, 170-176.
23. Mullins, D.E. & Rohrlich, S.T. (1985) The role of proteinases in cellular invasiveness. Biochimica et Biophysica Acta, 695, 177-214.
24. Nielsen, L.S., Hansen, J.G., Skriver, L., Wilsen, E.L., Kaltoft, K., Zeuthen, J. & Dano, K. (1982) Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody. Biochemistry, 21, 6410-6415.
25. O'Grady, R.L., Upfold, L.I. & Stephens, R.W. (1981) Rat mammary carcinoma cells secrete active collagenase and activate latent enzyme in the stroma via plasminogen activator. International Journal of Cancer, 28, 509-515.
26. Prokopowicz, J. & Stormorken, H. (1968) Fibrinolytic activity of leukocytes in smears of bone marrow and peripheral blood. Scandinavian Journal of Haematology, 5, 129-137.
27. Ritchie, H., Jamieson, A. & Booth, N.A. (1995) Thrombin modulates synthesis of plasminogen activator inhibitor 2 by human peripheral blood monocytes. Blood, 86, 3428-3435.
28. Robbie, L.A., Bennett, B., Brown, P.A.J., Croll, A.M. & Booth, N.A. (1996) Activators and inhibitors of the fibrinolytic system in human thrombi. Thrombosis and Haemostasis, 75, 127-133.
29. Salo, T., Liotta, L.A., Keski-Oja, J., Turpeenniemi-Hujanen, T. & Tryggvason, K. (1982) Secretion of basement collagen degrading enzyme and plasminogen activator by transformed cells: role in metastasis. International Journal of Cancer, 30, 669-673.
30. Sappino, A-P., Busso, N., Belin, D. & Vassalli, J-D. (1987) Increase of urokinase-type plasminogen activator gene expression in human lung and breast carcinoma. Cancer Research, 47, 4043-4046.
31. Sheela, S. & Barrett, J.C. (1982) In vitro degradation of intact basement membrane mediated by cellular plasminogen activator. Carcinogenesis, 3, 363-369.
32. Skriver, L., Larsson, L.-I., Kielberg, V., Neilsen, L.S., Andreasen, P.A., Kristensen, P. & Dano, K. (1982) Immunocytochemical localisation of urokinase-type plasminogen activator in Lewis lung carcinoma. Journal of Cell Biology, 99, 752-757.
33. Stephens, R., Alitalo, R., Tapiovaara, H. & Vaheri, A. (1988) Production of urokinase by leukemia cells; a novel distinction from cell lines of solid tumors. Leukemia Research, 12, 419-422.
34. Stephens, R.W., Fordham, C.J. & Doe, W.F. (1987) Proenzyme to urokinase-type plasminogen activator in human colon cancer: in vitro inhibition by monocyte minactivin after proteolytic activation. European Journal of Cancer and Clinical Oncology, 23, 213-222.
35. Stump, D.C., Lijnen, H.R. & Collen, D. (1986) Purification and characterisation of single-chain urokinase-type plasminogen activator from human cell cultures. Journal of Biological Chemistry, 261, 1274-1278.
36. Tallman, M.S. & Kwaan, H.C. (1992) Reassessing the hemostatic disorder associated with acute promyelocytic leukemia. Blood, 79, 543-553.
37. Tapiovaara, H., Matikainen, S., Hurme, M. & Vaheri, A. (1994) Induction of differentiation of promyelocytic NB4 cells by retinoic acid is associated with rapid increase in urokinase activity subsequently down regulated by production of inhibitors. Blood, 83, 1883-1891.
38. Wilson, E.L. & Francis, G.A. (1987) Differentiation-linked secretion of plasminogen activators by human myeloid leukemia cells in vitro. Blood, 61, 568-574.
39. Wun, T.C., Ossowski, L. & Reich, E. (1982) A proenzyme form of human urokinase. Journal of Biological Chemistry, 257, 7262-7268.